These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15878894)

  • 1. Recombinant factor VIIa fails to correct coagulopathy induced by haemodilution with colloid.
    Sørensen B; Fenger-Eriksen C; Ingerslev J
    Br J Anaesth; 2005 Jun; 94(6):862-3. PubMed ID: 15878894
    [No Abstract]   [Full Text] [Related]  

  • 2. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
    Dickneite G; Dörr B; Kaspereit F; Tanaka KA
    J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center.
    Brown CV; Sowery L; Curry E; Valadka AB; Glover CS; Grabarkewitz K; Green T; Hail S; Admire J
    Am Surg; 2012 Jan; 78(1):57-60. PubMed ID: 22273315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of a coagulopathy using recombinant factor VII before removal of an intra-aortic balloon pump.
    Tobias JD; Berkenbosch JW; Muruve NA; Schmaltz RA
    J Cardiothorac Vasc Anesth; 2002 Oct; 16(5):612-4. PubMed ID: 12407616
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant factor VIIa: how safe is the stuff?
    Roberts HR
    Can J Anaesth; 2005 Jan; 52(1):8-11. PubMed ID: 15625249
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs.
    Grottke O; Braunschweig T; Zimmermann L; Kopp R; Lauritzen B; Coburn M; Tolba R; Rossaint R
    Br J Anaesth; 2010 Dec; 105(6):789-97. PubMed ID: 20926476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of trauma-induced coagulopathy: trends and practices.
    D'Angelo MR; Dutton RP
    AANA J; 2010 Feb; 78(1):35-40. PubMed ID: 20977127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant factor VIIa for uncontrolled bleeding in 2 different cases of coagulopathy.
    Islam J; Azhar S; Alperin JB; Syed I
    J Am Board Fam Pract; 2003; 16(6):549-52. PubMed ID: 14963082
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring recombinant factor VIIa treatment: efficacy depends on high levels of fibrinogen in a model of severe dilutional coagulopathy.
    Ganter MT; Schmuck S; Hamiel CR; Wischmeyer PE; Heule D; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):675-80. PubMed ID: 18922422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
    Mindikoglu AL; Anantharaju A; George M; Leone N; Bejna J; Van Thiel DH
    Hepatogastroenterology; 2003; 50(53):1697-9. PubMed ID: 14571820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant activated factor VII in approved indications: Update on safety.
    Neufeld EJ; Négrier C; Benchikh El Fegoun S; Cooper DL; Rojas-Rios A; Seremetis S
    Haemophilia; 2018 Jul; 24(4):e275-e277. PubMed ID: 30004625
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor.
    William BM
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):327-8. PubMed ID: 18469559
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device.
    Zietkiewicz M; Garlicki M; Domagała J; Wierzbicki K; Drwiła R; Pfitzner R; Dziatkowiak A
    J Thorac Cardiovasc Surg; 2002 Feb; 123(2):384-5. PubMed ID: 11828314
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose recombinant factor VIIa for trauma patients with coagulopathy.
    Stein DM; Dutton RP; Hess JR; Scalea TM
    Injury; 2008 Sep; 39(9):1054-61. PubMed ID: 18656871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulopathy induced by colloid plasma expanders--search for an efficacious haemostatic intervention.
    Fenger-Eriksen C; Ingerslev J; Sørensen B
    Acta Anaesthesiol Scand; 2006 Aug; 50(7):899-900. PubMed ID: 16879481
    [No Abstract]   [Full Text] [Related]  

  • 16. Coagulation factor VIIa (recombinant) in nonhemophilic patients requiring neurosurgery.
    Culley CM; Guttendorf S; Coldren M; Skledar SJ; Gross PR; Spiro RM; Triulzi DJ; Ragni MV
    Am J Health Syst Pharm; 2009 Sep; 66(17):1554-9. PubMed ID: 19710439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant factor VIIa in liver diseases.
    Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Replacement therapy of coagulation factor preparations: antithrombin, FFP, PPSB, FXIII, rFVIIa].
    Scharrer I
    Hamostaseologie; 2005 May; 25(2):209-12. PubMed ID: 15924160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidosis and impaired blood coagulation: what and how to correct before using recombinant human factor VIIa.
    Dempfle CE; Borggrefe M
    Crit Care Med; 2007 Jun; 35(6):1627-9. PubMed ID: 17522543
    [No Abstract]   [Full Text] [Related]  

  • 20. Time for changing coagulation management in trauma-related massive bleeding.
    Fries D; Innerhofer P; Schobersberger W
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):267-74. PubMed ID: 19390253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.